Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
521.00    0.00 (0.00%)
Bid:
521.00
Ask:
525.00
Spread: 4.00 (0.768%)
Market Cap: £511.64m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Update Statement on 2020 AGM results

2 Feb 2021 12:00

RNS Number : 6937N
Galliford Try Holdings PLC
02 February 2021
 

Galliford Try Holdings plc

("Galliford Try")

 

Update Statement on 2020 AGM results

 

Galliford Try issues this further statement in relation to the 2020 AGM vote on the Directors' Remuneration Report (Resolution 2).

 

At Galliford Try's AGM held on 13 November 2020, the advisory vote on the Directors' Remuneration Report (Resolution 2) was passed by shareholders with 64.43% voting in favour. In consultation with major shareholders and proxy advisors, the Board understands that shareholders' concern was the Finance Director's 2019/20 annual bonus where 50% was based on the successful completion of the disposal of the Group's housebuilding divisions in January 2020.

 

Whilst appreciating the view of many shareholders that 'transaction-focused' measures should not be regularly included in Executive Director incentives, the Remuneration Committee's decision to base half of the Finance Director's 2019/2020 annual bonus on the successful completion of the disposal reflected that this transformational corporate transaction represented a significant focus of the Finance Director's duties and responsibilities in the 2019/20 financial year. In making the award in respect of the disposal, the Remuneration Committee carefully considered the one-off nature of the transaction in the context of the Finance Director's wider contribution and the underlying performance of the Group. This decision was permitted under the remit of the Remuneration Committee and the Company's Remuneration Policy.

 

The Board will continue to engage with shareholders to ensure their views are fully understood and considered and can be taken into account by the Committee in the future.

 

 

 

For further enquiries:

Galliford Try Holdings plc

Kevin Corbett, General Counsel & Company Secretary

01895 855001

 

 

 

Note to Editors

 

Galliford Try is a trading name of Galliford Try Holdings plc, a leading UK construction group listed on the London Stock Exchange. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure projects with clients in the public, private and regulated sectors across the UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMGIGDDGUGDGBD
Date   Source Headline
1st Jun 202610:00 amRNSTotal Voting Rights
29th May 202610:45 amRNSHolding(s) in Company
28th May 20264:10 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
7th May 20267:00 amRNSInvestor and Analyst Site Visit
1st May 202610:00 amRNSTotal Voting Rights
23rd Apr 202610:30 amRNSReplacement: Completion of Share Buyback Programme
22nd Apr 20267:10 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20264:25 pmRNSContract
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20264:15 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20262:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 202610:00 amRNSDirector/PDMR Shareholding
4th Mar 20263:00 pmRNSReplacement - Transaction in Own Shares
4th Mar 20267:00 amRNSHalf-year Financial Report
2nd Mar 202610:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSContract
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 202610:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:02 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.